Skip to content

Database study on treatment status and clinical symptoms in patients with chronic hypoparathyroidism

Treatment status and clinical symptoms in patients with chronic hypoparathyroidism: a retrospective cross-sectional study using real-world data - Treatment status and clinical symptoms in patients with chronic hypoparathyroidism: a retrospective cross-sectional study using real-world data

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000056749
Enrollment
2000
Registered
2025-01-17
Start date
2025-01-20
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypoparathyroidism

Interventions

None listed

Sponsors

Teijin Pharma Limited
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who met the criteria for hypoparathyroidism and were prescribed conventional drug regimen between 180 and 300 days after meeting those criteria, from January 1, 2016 to June 30, 2024.

Exclusion criteria

Exclusion criteria: Not applicable

Design outcomes

Primary

MeasureTime frame
(1) Patient characteristics (patient demographics, laboratory test results, and comorbidities) (2) Treatment status (actual status of prescriptions under conventional therapy, and status of serum calcium level control under that therapy) (3) Clinical symptoms

Countries

Japan

Contacts

Public ContactMana Kujirai

Teijin Pharma Limited Medical Science Department

tpm-com@umin.ac.jp03-3506-4140

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026